Paxman AB (publ) (STO:PAX)

Market Cap	1.23B -6.2%
Revenue (ttm)	323.56M +20.7%
Net Income	-16.72M -81.9%
EPS	-0.72 -83.0%
Shares Out	23.27M
PE Ratio	n/a
Forward PE	29.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,614
Average Volume	24,358
Open	49.20
Previous Close	51.00
Day's Range	47.10 - 54.00
52-Week Range	41.00 - 85.80
Beta	0.45
RSI	61.07
Earnings Date	Feb 20, 2026

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 142
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.